Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graybill

Showing results (501-510 of 539) with videos related to

Pageof 54
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infectionsIssam I Raad, John R Graybill, Ana Beatriz Bustamante, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2023
Progression-free survival and safety at 3.5years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancerAntonio González-Martín, Bhavana Pothuri, Ignace Vergote, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2010
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of americaJohn R Perfect, William E Dismukes, Francoise Dromer, et al.
Future Oncology (London, England)|March 19, 2024
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summaryAntonio González-Martín, Bhavana Pothuri, Ignace Vergote, et al.
Journal of Medicinal Chemistry|April 11, 2013
Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3Jeremy S Disch, Ghotas Evindar, Cynthia H Chiu, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|October 27, 2005
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbitsJoseph M Harrison, Randolph D Glickman, Charles S Ballentine, et al.
Annals of Internal Medicine|January 1, 1983
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal studyW E Dismukes, A M Stamm, J R Graybill, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitorsKaren A Evans, Yue H Li, Frank T Coppo, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonistsYonghui Wang, Jakob Busch-Petersen, Feng Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDSP K Sharkey, J R Graybill, E S Johnson, et al.
Pageof 54

Showing results (501-510 of 539) with videos related to

Sort By:
Pageof 54
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infectionsIssam I Raad, John R Graybill, Ana Beatriz Bustamante, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2023
Progression-free survival and safety at 3.5years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancerAntonio González-Martín, Bhavana Pothuri, Ignace Vergote, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2010
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of americaJohn R Perfect, William E Dismukes, Francoise Dromer, et al.
Future Oncology (London, England)|March 19, 2024
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summaryAntonio González-Martín, Bhavana Pothuri, Ignace Vergote, et al.
Journal of Medicinal Chemistry|April 11, 2013
Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3Jeremy S Disch, Ghotas Evindar, Cynthia H Chiu, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|October 27, 2005
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbitsJoseph M Harrison, Randolph D Glickman, Charles S Ballentine, et al.
Annals of Internal Medicine|January 1, 1983
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal studyW E Dismukes, A M Stamm, J R Graybill, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitorsKaren A Evans, Yue H Li, Frank T Coppo, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonistsYonghui Wang, Jakob Busch-Petersen, Feng Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDSP K Sharkey, J R Graybill, E S Johnson, et al.
Pageof 54